The diagnosis of acute intermittent porphyria (AIP) is often overlooked. We describe a patient with this condition who had all the ‘bells and whistles’, in whom the diagnosis was only made after considerable delay. Far from an esoteric condition haunting examination candidates, AIP is an important cause of a broad spectrum of neurological symptoms. Its early recognition allows the astute clinician to prevent potentially devastating sequelae. We provide practical guidance on the investigation and management of this complex disorder. With a ‘back to basics’ approach to the underlying genetics and biochemistry, we hope to dispel some of the confusion that may obstruct a timely diagnosis.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Contributors ROM: first draft of manuscript and revision. GR and PS: revision of first draft. OB: overall responsibility for revisions, submission and resubmission.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Commissioned; externally peer reviewed. This paper was reviewed by Herbert Bonkovsky, North Carolina, USA.
Read the full text or download the PDF:
Other content recommended for you
- Unexpected presentation of acute porphyria
- Diagnosis and management of porphyria
- Update on the diagnosis and management of the autosomal dominant acute hepatic porphyrias
- Cerebral vasospasm and anterior circulation stroke secondary to an exacerbation of hereditary corproporphyria
- Neuropsychiatric porphyria in patients with refractory epilepsy: report of three cases
- A review of the clinical presentation, natural history and inheritance of variegate porphyria: its implausibility as the source of the ‘Royal Malady’
- Review of hepatocellular cancer, hypertension and renal impairment as late complications of acute porphyria and recommendations for patient follow-up
- Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria
- Porphyria for the neurologist: the bare essentials
- Acute intermittent porphyria presenting with posterior reversible encephalopathy syndrome (PRES) and abdominal pain